Expert Insights On Decentralized Trials
-
Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
4/30/2024
MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
The Rise, Fall, And Eventual Rebound Of DCTs
3/25/2024
First there was skepticism, then enthusiasm, and then disillusionment. DCTs have had their ups and downs. Here, we're looking ahead to the future of DCTs.
-
Post-Pandemic Planning: Using Direct-To-Patient Deliveries For Supply Chain Management
2/23/2024
UCB Vice President – Head of Global Clinical Science and Operations Tero Laulajainen gets us up to speed on direct-to-patient (DTP) trials and how UCB is leveraging it today.
-
4 Things I Learned At SCOPE 2024
2/21/2024
The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.
-
4 Things I’m Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
3 Ways Biotechs Can Lower The Cost Of Clinical Trials
1/23/2024
LongeVC has identified three innovative models to help biotechs lower the cost of their clinical trials.
-
The 3 Big Downsides To DCTs
1/8/2024
James Gillespie, Ph.D., and Gregory Privitera, Ph.D. discuss three overlapping categories of concern when it comes to DCTs: consent and selection, user experience, and comfort and privacy.
-
What Clinical Trial Experts Think Will Happen With DCTs In 2024
12/28/2023
In part three of this preview of clinical trials trends, experts discuss the state of decentralized trials in all their permutations and muse on their fates as we enter 2024.
-
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?
9/22/2023
While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.